Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
US Cosmetic Updates - Modernization of Cosmetics Regulation Act (MoCRA)
Description
The transcript discusses the recent updates to U.S. cosmetic regulations under the Modernization of Cosmetics Regulation Act (MoCRA). It outlines the historical context of cosmetic regulation, beginning with the Federal Food, Drug, and Cosmetic Act of 1938, which included cosmetic safety after a notable incident involving harmful dyes. With the enactment of MoCRA in 2022, the FDA now has enhanced authority over cosmetics, implementing new regulations like mandatory registration, labeling requirements, and adverse event reporting, aiming to address safety and transparency. MoCRA defines 'serious adverse events' related to cosmetics and necessitates reporting these within a specified timeframe. The FDA also launched an electronic registration portal and has outlined plans for good manufacturing practices, safety substantiation, and monitoring of specific ingredients like PFAS and talc. The agency emphasizes that while animal testing is not required, safety must be substantiated through records kept by manufacturers. Other research efforts include addressing allergens in cosmetics and inspecting products like tattoo inks for contamination. The focus is also on education for consumers regarding ingredient safety and potential allergic reactions. Overall, the updates signify a shift towards increased oversight and consumer protection in the cosmetic industry.
View moreConclusions
- The Modernization of Cosmetics Regulation Act (MoCRA) introduces significant changes to the regulatory framework for cosmetics in the U.S.
- MoCRA mandates premarket registration and product listing for cosmetic products, shifting from voluntary to mandatory compliance.
- Serious adverse events associated with cosmetics must be reported to the FDA within a specified timeline, which enhances post-market safety surveillance.
- New labeling requirements under MoCRA will provide consumers with better information about cosmetic products, including fragrance allergens and contact details for the responsible person.
- MoCRA establishes Good Manufacturing Practices (GMP) for cosmetic manufacturing to ensure product safety and compliance with health standards.
- The FDA will regulate the presence of asbestos in talc-containing cosmetics to better protect consumer health.
- Research on the safety and allergenicity of cosmetic ingredients is prioritized under MoCRA, promoting better consumer health outcomes.
- The act prohibits certain practices, including the failure to report adverse events and the refusal of recalls, enhancing accountability in the cosmetics industry.
- Small businesses are granted exemptions from certain provisions of MoCRA, ensuring that regulatory burdens do not hinder their operations.
- Alinaghi et al. Contact Dermatitis 80:77-85, 2019
- Pastor-Nieto, 2021
- Nho S et al. J Appl Microbiol. 2018, 124:1294-1302.
- Yoon S et al. Microorganisms. 2022, 10: 820.
- Avonto et al. 2018. Toxicol. In Vitro. 46:237-245; Avonto et al. 2019. J.App.Toxicol. 39:398-408
- Avonto et al. 2018. J.App.Toxicol. 38:1047-1053
- Vukmanovic, & Sadrieh. 2017. Crit.Rev.Toxicol. 47:415-432
- Shutte et al. 2019. Contact Dermatitis. 81(3):174-183
- Salminen et al. Toxicology in Vitro. 2023. 91:105630. doi: 10.1016/j.tiv.2023.105630